Correlation Between NYSE Composite and Artiva Biotherapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on NYSE Composite and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Artiva Biotherapeutics,.

Diversification Opportunities for NYSE Composite and Artiva Biotherapeutics,

NYSEArtivaDiversified AwayNYSEArtivaDiversified Away100%
0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between NYSE and Artiva is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of NYSE Composite i.e., NYSE Composite and Artiva Biotherapeutics, go up and down completely randomly.
    Optimize

Pair Corralation between NYSE Composite and Artiva Biotherapeutics,

Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.14 times more return on investment than Artiva Biotherapeutics,. However, NYSE Composite is 7.23 times less risky than Artiva Biotherapeutics,. It trades about -0.29 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about -0.15 per unit of risk. If you would invest  2,020,982  in NYSE Composite on September 28, 2024 and sell it today you would lose (84,532) from holding NYSE Composite or give up 4.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NYSE Composite  vs.  Artiva Biotherapeutics, Common

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -20-1001020
JavaScript chart by amCharts 3.21.15NYA ARTV
       Timeline  

NYSE Composite and Artiva Biotherapeutics, Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-1.01-0.73-0.45-0.17-0.01290.09770.370.650.931.21 0.20.40.60.8
JavaScript chart by amCharts 3.21.15NYA ARTV
       Returns  

Pair Trading with NYSE Composite and Artiva Biotherapeutics,

The main advantage of trading using opposite NYSE Composite and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.
The idea behind NYSE Composite and Artiva Biotherapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA


 

Discover investing ideas

Utilize additional investing modules